Journal
GENETICS IN MEDICINE
Volume 24, Issue 3, Pages 631-644Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.gim.2021.10.014
Keywords
Congenital heart disease; Facial dysmorphism; Hyaluronidase; Myopia; Orofacial clefting
Categories
Ask authors/readers for more resources
This study provides further characterization and understanding of the disease caused by HYAL2 gene variants, which are associated with syndromic cleft lip/palate. Clinical and molecular investigations identified novel pathogenic variants and confirmed the consistent clinical manifestations of the condition. In silico modeling and functional studies shed light on the pathogenicity and molecular basis of the disease.
Purpose: We previously defined biallelic HYAL2 variants causing a novel disorder in 2 families, involving orofacial clefting, facial dysmorphism, congenital heart disease, and ocular abnormalities, with Hyal2 knockout mice displaying similar phenotypes. In this study, we better define the phenotype and pathologic disease mechanism. Methods: Clinical and genomic investigations were undertaken alongside molecular studies, including immunoblotting and immunofluorescence analyses of variant/wild-type human HYAL2 expressed in mouse fibroblasts, and in silico modeling of putative pathogenic variants. Results: Ten newly identified individuals with this condition were investigated, and they were associated with 9 novel pathogenic variants. Clinical studies defined genotype-phenotype correlations and confirmed a recognizable craniofacial phenotype in addition to myopia, cleft lip/palate, and congenital cardiac anomalies as the most consistent manifestations of the condition. In silico modeling of missense variants identified likely deleterious effects on protein folding. Consistent with this, functional studies indicated that these variants cause protein instability and a concomitant cell surface absence of HYAL2 protein. Conclusion: These studies confirm an association between HYAL2 alterations and syndromic cleft lip/palate, provide experimental evidence for the pathogenicity of missense alleles, enable further insights into the pathomolecular basis of the disease, and delineate the core and variable clinical outcomes of the condition. (C) 2021 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available